Collateral can become constrained
before performance metrics show stress.
Equus Capital Advisory identifies warrantability presentation defects and documentation gaps that can impair refinanceability, sale, or securitization under LL-2026-03 — typically before they appear in delinquency or surveillance reporting.
On 03 August 2026, the Fannie Mae Full Review standard under LL-2026-03 becomes effective. Condo and co-op questionnaires that interact with the conforming channel are graded against an expanded standard on a pass / fail basis.
Loans secured by buildings whose questionnaires fail Full Review remain operationally performing while becoming ineligible for sale or refinance through the conforming channel. The effect is on liquidity and collateral classification, not on credit performance.
Examiners and counterparty lenders will read questionnaires against the new standard after 03 August. Constrained collateral that has not been identified and addressed before then is more likely to surface as a reclassification event with its own documentary record.
Under documented Full Review failure scenarios, portfolio-level exposure is generally estimated in a 10–30% band of in-scope balance, depending on building composition. Standard performance reporting does not surface this exposure; it surfaces during exit, refinance, or examination.
The number below makes question four concrete for your portfolio — the share of performing balance that, under these assumptions, sits in constrained collateral status.
Estimating constrained-collateral exposure across the portfolio
Under these assumptions, warrantability defects could expose between the low and high bands shown below as collateral that cannot exit through the conforming channel. The model is illustrative; portfolio-level review is required to determine actual exposure.
Indicative constrained-collateral exposure
Adjust the inputs to your in-scope portfolio. Under these assumptions, warrantability defects producing Full Review failures could expose between the low and high bands shown as collateral that cannot exit through the conforming channel — independent of credit performance.
// Constrained collateral does not present as delinquent. It presents as performing — until it must be sold, refinanced, or securitized. Portfolio-level review is required to determine actual exposure.
Why constrained-collateral risk is not visible in standard surveillance
Standard servicer dashboards surface delinquency, prepayment, and modification activity. Warrantability defects are none of these. They reside in the documentation of the underlying property and remain invisible to loan-level reporting until a transaction is attempted.
Performance reporting
A constrained loan continues to perform. Delinquency, prepayment, and modification cohorts treat it as healthy. The defect resides in the questionnaire, not the payment record.
Standard credit review
Credit metrics — FICO, LTV, DTI, reserves — pass. The defect is structural and documentary, not statistical, and is not surfaced by standard credit screens.
Independent forensic review
Reading the questionnaire alongside the supporting reserve study, entity standing, insurance schedule, and loan documentation as a connected record is what surfaces the defect. That review is the Equus offering.
Portfolio-level review and warrantability triage
Equus applies the building-level review at portfolio scale. Buildings are sampled or fully reviewed, classified, and routed: pass, curable, structural. The output supports internal credit, surveillance, and disposition processes, and is structured for examiner review.
Portfolio sampling or full review
Each in-scope building is run through the assessment framework. The output is a pass / curable / structural classification, with an indicative per-building exposure band.
Warrantability triage
Curable buildings are sequenced by cost-to-cure, time-to-cure, and exposure released. The triage informs a remediation pipeline rather than a single memorandum.
Examiner-ready documentation
Outputs are structured for use with regulators, counterparty lenders, and credit committees without further translation. The narrative the institution wishes to present is the narrative the documentation supports.
The four readers of this brief
Lenders and servicers
Institutions responsible for condo and co-op exposure under secondary-market obligations. Constrained collateral is the institution's event, not the borrower's.
Regional banks
Concentrated geographic exposure. A single mid-rise can materially affect the warrantability profile of a regional condo portfolio.
Allocators and investors
Counterparties to MBS, CMBS, and securitization programs, and allocators evaluating manager exposure. Warrantability sits upstream of every securitization decision.
Examiners and oversight bodies
Reviewing condo books for classification accuracy and disclosure adequacy. Documentation is structured to match the standard of review, neither above nor below.
Institutional documentation
Portfolio determination
Pass / curable / structural classification for each in-scope building, with the supporting reasoning. Designed as the artifact a regulator or credit committee will request first.
Remediation pipeline
Sequenced cure roadmap across the portfolio, with indicative cost-to-cure and time-to-cure by building, used to inform internal prioritization.
Exposure book
Banded exposure across the portfolio, segmented by classification and remediation status. Used by counterparty lenders, allocators, and internal credit committees to underwrite the portfolio.
How exposure evolves
Three stages, evaluated in sequence. The cost characteristics of each stage are different, and the order is fixed.
Findings can be remediated under board control, with sequencing and disclosure managed internally. Cost is contained; the documentary record is private to the engagement.
The Full Review standard becomes effective. Each warrantability questionnaire is graded against the expanded standard. Presentation, custody, or disclosure defects can fail the building on submission.
Exposure crystallizes as constrained collateral and observable repricing in the 10–25% band. Refinance and sale activity contract; documentation is reviewed under counterparty and examiner standards.
Engage a portfolio-level review
Provide portfolio size, geography, and a point of contact. Equus will respond with a scope letter, an in-scope building count, and an indicative exposure band within five business days.